Stock Taper
NRC
NRC HEALTH
NASDAQ
$20.42
▲ UP 1.14% (0.23)

KEY STATISTICS

Market Cap$460.42 M
52w High$23.68
52w Low$11.01
Dividend Yield3.38%
FrequencyQuarterly
P/E24.90
Volume99.24K
Shares Out.22.54M

COMPANY

LEADERSHIP

Trent Green
CHIEF EXECUTIVE
Trent Green

COMPENSATION 2026

Salary$697,115
Stock Awards$6,755,000
Incentive Plan Pay$0
All Other Comp.$6,452
Total$11,961,900

ABOUT

SECTOR
Healthcare
WENT PUBLIC
May 23, 2013
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
357

UPCOMING EARNINGS

DateOct 26, 2026
DayMonday
Rev. Est.$35.80M
OCT
26
MON

ETFS HOLDING THIS STOCK

ETFS HOLDING
100
LISTED HERE
10
RANKED BY POSITION SIZE

INSTITUTIONAL OWNERSHIP

SHARES OWNED
38.75%
HOLDERS
186
TOP 8 OF 186 · RANKED BY POSITION SIZE

PRICE

$20.42 ▲ UP 1.14% (+$0.23)
$20.00$20.20$20.409:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM20.42

About NRC Health

https://nrchealth.com ↗

National Research Corporation offers analytics and insights to healthcare organizations in the U.S. and Canada, enhancing patient and employee experiences, market perception, care transitions, and population health management through subscription-...

INDUSTRY

Medical - Healthcare Information Services

A SERVICE NRC HEALTH IS KNOWN FOR

Human Understanding® Platform

A subscription SaaS platform offering healthcare organizations data analytics and AI-driven insights via 'Huey™' to improve patient and employee experiences and promote human-centered care.

NRC Health in 2025

SENTIMENT: + POSITIVE
EARNINGS · OCTOBER 2025

National Research Corporation Announces Strong Q3 2025 Results and 33% Dividend Increase, Sparking Significant Stock Rally Under New CEO

National Research Corporation reported a strong third quarter in 2025, with an 8% year-over-year increase in Total Recurring Contract Value (TRCV) to $141.7 million and an 11% increase in adjusted EBITDA. This positive report, following a mixed Q2 with a net loss, was delivered under the new leadership of CEO Trent Green and was accompanied by the announcement of a 33% increase in the quarterly dividend, signaling a significant turnaround and leading to a substantial increase in the company's stock price.

CAPITAL ALLOCATION · OCTOBER 15, 2025 · ANNOUNCED

National Research Corporation Announces 33% Dividend Increase, Signaling Confidence and Enhanced Shareholder Returns

National Research Corporation's Board of Directors declared a 33% increase to its quarterly cash dividend, raising it from $0.12 to $0.16 per share. This decision reflects the company's strong financial performance, positive outlook, and commitment to delivering value to its shareholders.

Latest News

DEFENSE WORLD · OCT 5, 2026

Head to Head Survey: National Research (NASDAQ:NRC) vs. Teladoc Health (NYSE:TDOC)

Teladoc Health (NYSE: TDOC - Get Free Report) and National Research (NASDAQ: NRC - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, risk, earnings, analyst recommendations and valuation. Earnings and Valuation This table compares Teladoc

EARLIER COVERAGE
NEWSFILE CORP · OCT 1, 2026

NANO Nuclear Energy Advances Vertical Integration Strategy by Signing Definitive Agreement to Acquire Strategic NRC-Licensed U.S. Nuclear Fuel Processing Assets

Acquisition would provide NANO Nuclear with strategically valuable NRC-licensed fuel cycle assets and optionality to pursue domestic nuclear fuel cycle activities, independently or in collaboration with strategic partners Upon completion of the transaction and transfer of the NRC license, NANO Nuclear would own one of ten NRC-licensed fuel cycle facilities in the United States New York, New York--(Newsfile Corp. - October 1, 2026) - NANO Nuclear Energy Inc. (NASDAQ: NNE) ("NANO Nuclear" or the "Company"), an advanced nuclear energy and technology company developing microreactors, nuclear fuel cycle capabilities and nuclear transportation solutions, today announced that NANO Nuclear and its wholly owned subsidiary, HALEU Energy Fuel Inc., have entered into a definitive asset purchase agreement with Radnostix, Inc. (formerly International Isotopes Inc.) and its subsidiary International Isotopes Fluorine Products, Inc. to acquire strategic U.S. nuclear fuel processing assets, including a U.S. Nuclear Regulatory Commission ("NRC") license and related intellectual property and technical materials associated with a previously planned depleted uranium hexafluoride ("DUF6") deconversion and fluorine extraction facility in Lea County, New Mexico. To view an enhanced version of this graphic, please visit: https://images.newsfilecorp.com/files/11703/316891_ce00829e142b3b35_001full.jpg The proposed acquisition would provide NANO Nuclear with existing NRC-licensed fuel cycle assets and a substantial body of associated licensing and technical work.

RATINGS SNAPSHOT

Overall rating: B

DCFROEROAD/EP/EP/B
Discounted Cash Flow4
Return On Equity5
Return On Assets5
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score3

MOST RECENT ANALYST GRADES

GRADE SUMMARY
MARKET OUTPERFORM 1
1 GRADES IN THE LAST 12 MONTHS

SECTORS PEERS

PEERPRICE
HSTM$32.37COMPARE
PHR$10.54COMPARE
SOPH$7.25COMPARE
PBYI$9.56COMPARE
CTEV$24.59COMPARE
VMD$9.36COMPARE
SPOK$10.98COMPARE
QTRX$3.50COMPARE

INSIDER TRADES

★
DIRECTOR
Wheeler Penny Ann
Purchase · 7.7K shares
2026-06-23
★
DIRECTOR
NUNNELLY JOHN N
Purchase · 7.7K shares
2026-06-23
★
DIRECTOR
Lockhart Stephen H
Purchase · 7.7K shares
2026-06-23
★
DIRECTOR
Bhandari Parul
Purchase · 7.7K shares
2026-06-23